The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Veterinary Anthrax Vaccines-Global Market Insights and Sales Trends 2024
Synopsis
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
The global Veterinary Anthrax Vaccines market size is expected to reach US$ 55 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Veterinary Anthrax Vaccines in various end use industries. The expanding demands from the Cow, Sheep, Swine and Other, are propelling Veterinary Anthrax Vaccines market. Cell Free PA Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Live Vaccines segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 104%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Veterinary Anthrax Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Veterinary Anthrax Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Veterinary Anthrax Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Veterinary Anthrax Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Veterinary Anthrax Vaccines covered in this report include Agrovet, Bayer Sanidad Animal, Biogenesis Bago SA, Botswana Vaccine Institute, Central Veterinary Control and Research Institute, Centro Diagnostico Veterinario, Ceva Sante Animale, Colorado Serum Company and Empresa Colombiana de Productos Veterinarios S.A, etc.
The global Veterinary Anthrax Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agrovet
Bayer Sanidad Animal
Biogenesis Bago SA
Botswana Vaccine Institute
Central Veterinary Control and Research Institute
Centro Diagnostico Veterinario
Ceva Sante Animale
Colorado Serum Company
Empresa Colombiana de Productos Veterinarios S.A
Indian Immunologicals Limited
Institute for Biological Products
Intervac (PVT) Ltd
JOVAC
Global Veterinary Anthrax Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Veterinary Anthrax Vaccines market, Segment by Type:
Cell Free PA Vaccines
Live Vaccines
Global Veterinary Anthrax Vaccines market, by Application
Cow
Sheep
Swine
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Veterinary Anthrax Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Veterinary Anthrax Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
The global Veterinary Anthrax Vaccines market size is expected to reach US$ 55 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Veterinary Anthrax Vaccines in various end use industries. The expanding demands from the Cow, Sheep, Swine and Other, are propelling Veterinary Anthrax Vaccines market. Cell Free PA Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Live Vaccines segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 104%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Veterinary Anthrax Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Veterinary Anthrax Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Veterinary Anthrax Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Veterinary Anthrax Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Veterinary Anthrax Vaccines covered in this report include Agrovet, Bayer Sanidad Animal, Biogenesis Bago SA, Botswana Vaccine Institute, Central Veterinary Control and Research Institute, Centro Diagnostico Veterinario, Ceva Sante Animale, Colorado Serum Company and Empresa Colombiana de Productos Veterinarios S.A, etc.
The global Veterinary Anthrax Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agrovet
Bayer Sanidad Animal
Biogenesis Bago SA
Botswana Vaccine Institute
Central Veterinary Control and Research Institute
Centro Diagnostico Veterinario
Ceva Sante Animale
Colorado Serum Company
Empresa Colombiana de Productos Veterinarios S.A
Indian Immunologicals Limited
Institute for Biological Products
Intervac (PVT) Ltd
JOVAC
Global Veterinary Anthrax Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Veterinary Anthrax Vaccines market, Segment by Type:
Cell Free PA Vaccines
Live Vaccines
Global Veterinary Anthrax Vaccines market, by Application
Cow
Sheep
Swine
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Veterinary Anthrax Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Veterinary Anthrax Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Veterinary Anthrax Vaccines Market Overview
1.1 Veterinary Anthrax Vaccines Product Overview
1.2 Veterinary Anthrax Vaccines Market Segment by Type
1.2.1 Cell Free PA Vaccines
1.2.2 Live Vaccines
1.3 Global Veterinary Anthrax Vaccines Market Size by Type
1.3.1 Global Veterinary Anthrax Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Veterinary Anthrax Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Veterinary Anthrax Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Veterinary Anthrax Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Veterinary Anthrax Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Veterinary Anthrax Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Veterinary Anthrax Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Veterinary Anthrax Vaccines Sales Breakdown by Type (2018-2023)
2 Global Veterinary Anthrax Vaccines Market Competition by Company
2.1 Global Top Players by Veterinary Anthrax Vaccines Sales (2018-2023)
2.2 Global Top Players by Veterinary Anthrax Vaccines Revenue (2018-2023)
2.3 Global Top Players by Veterinary Anthrax Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Veterinary Anthrax Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Veterinary Anthrax Vaccines Market Competitive Situation and Trends
2.5.1 Veterinary Anthrax Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Veterinary Anthrax Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Anthrax Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Veterinary Anthrax Vaccines Market
2.8 Key Manufacturers Veterinary Anthrax Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Veterinary Anthrax Vaccines Status and Outlook by Region
3.1 Global Veterinary Anthrax Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Veterinary Anthrax Vaccines Historic Market Size by Region
3.2.1 Global Veterinary Anthrax Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Veterinary Anthrax Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Veterinary Anthrax Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Veterinary Anthrax Vaccines Forecasted Market Size by Region
3.3.1 Global Veterinary Anthrax Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Veterinary Anthrax Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Veterinary Anthrax Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Veterinary Anthrax Vaccines by Application
4.1 Veterinary Anthrax Vaccines Market Segment by Application
4.1.1 Cow
4.1.2 Sheep
4.1.3 Swine
4.1.4 Other
4.2 Global Veterinary Anthrax Vaccines Market Size by Application
4.2.1 Global Veterinary Anthrax Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Veterinary Anthrax Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Veterinary Anthrax Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Veterinary Anthrax Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Veterinary Anthrax Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Veterinary Anthrax Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Veterinary Anthrax Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Veterinary Anthrax Vaccines Sales Breakdown by Application (2018-2023)
5 North America Veterinary Anthrax Vaccines by Country
5.1 North America Veterinary Anthrax Vaccines Historic Market Size by Country
5.1.1 North America Veterinary Anthrax Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Veterinary Anthrax Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Veterinary Anthrax Vaccines Sales in Value by Country (2018-2023)
5.2 North America Veterinary Anthrax Vaccines Forecasted Market Size by Country
5.2.1 North America Veterinary Anthrax Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Veterinary Anthrax Vaccines Sales in Value by Country (2024-2029)
6 Europe Veterinary Anthrax Vaccines by Country
6.1 Europe Veterinary Anthrax Vaccines Historic Market Size by Country
6.1.1 Europe Veterinary Anthrax Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Veterinary Anthrax Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Veterinary Anthrax Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Veterinary Anthrax Vaccines Forecasted Market Size by Country
6.2.1 Europe Veterinary Anthrax Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Veterinary Anthrax Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Veterinary Anthrax Vaccines by Region
7.1 Asia-Pacific Veterinary Anthrax Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Veterinary Anthrax Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Veterinary Anthrax Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Veterinary Anthrax Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Veterinary Anthrax Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Veterinary Anthrax Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Veterinary Anthrax Vaccines Sales in Value by Region (2024-2029)
8 Latin America Veterinary Anthrax Vaccines by Country
8.1 Latin America Veterinary Anthrax Vaccines Historic Market Size by Country
8.1.1 Latin America Veterinary Anthrax Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Veterinary Anthrax Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Veterinary Anthrax Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Veterinary Anthrax Vaccines Forecasted Market Size by Country
8.2.1 Latin America Veterinary Anthrax Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Veterinary Anthrax Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Veterinary Anthrax Vaccines by Country
9.1 Middle East and Africa Veterinary Anthrax Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Veterinary Anthrax Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Veterinary Anthrax Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Veterinary Anthrax Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Veterinary Anthrax Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Veterinary Anthrax Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Veterinary Anthrax Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Agrovet
10.1.1 Agrovet Company Information
10.1.2 Agrovet Introduction and Business Overview
10.1.3 Agrovet Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Agrovet Veterinary Anthrax Vaccines Products Offered
10.1.5 Agrovet Recent Development
10.2 Bayer Sanidad Animal
10.2.1 Bayer Sanidad Animal Company Information
10.2.2 Bayer Sanidad Animal Introduction and Business Overview
10.2.3 Bayer Sanidad Animal Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bayer Sanidad Animal Veterinary Anthrax Vaccines Products Offered
10.2.5 Bayer Sanidad Animal Recent Development
10.3 Biogenesis Bago SA
10.3.1 Biogenesis Bago SA Company Information
10.3.2 Biogenesis Bago SA Introduction and Business Overview
10.3.3 Biogenesis Bago SA Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Biogenesis Bago SA Veterinary Anthrax Vaccines Products Offered
10.3.5 Biogenesis Bago SA Recent Development
10.4 Botswana Vaccine Institute
10.4.1 Botswana Vaccine Institute Company Information
10.4.2 Botswana Vaccine Institute Introduction and Business Overview
10.4.3 Botswana Vaccine Institute Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Botswana Vaccine Institute Veterinary Anthrax Vaccines Products Offered
10.4.5 Botswana Vaccine Institute Recent Development
10.5 Central Veterinary Control and Research Institute
10.5.1 Central Veterinary Control and Research Institute Company Information
10.5.2 Central Veterinary Control and Research Institute Introduction and Business Overview
10.5.3 Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Products Offered
10.5.5 Central Veterinary Control and Research Institute Recent Development
10.6 Centro Diagnostico Veterinario
10.6.1 Centro Diagnostico Veterinario Company Information
10.6.2 Centro Diagnostico Veterinario Introduction and Business Overview
10.6.3 Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Products Offered
10.6.5 Centro Diagnostico Veterinario Recent Development
10.7 Ceva Sante Animale
10.7.1 Ceva Sante Animale Company Information
10.7.2 Ceva Sante Animale Introduction and Business Overview
10.7.3 Ceva Sante Animale Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Ceva Sante Animale Veterinary Anthrax Vaccines Products Offered
10.7.5 Ceva Sante Animale Recent Development
10.8 Colorado Serum Company
10.8.1 Colorado Serum Company Company Information
10.8.2 Colorado Serum Company Introduction and Business Overview
10.8.3 Colorado Serum Company Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Colorado Serum Company Veterinary Anthrax Vaccines Products Offered
10.8.5 Colorado Serum Company Recent Development
10.9 Empresa Colombiana de Productos Veterinarios S.A
10.9.1 Empresa Colombiana de Productos Veterinarios S.A Company Information
10.9.2 Empresa Colombiana de Productos Veterinarios S.A Introduction and Business Overview
10.9.3 Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Products Offered
10.9.5 Empresa Colombiana de Productos Veterinarios S.A Recent Development
10.10 Indian Immunologicals Limited
10.10.1 Indian Immunologicals Limited Company Information
10.10.2 Indian Immunologicals Limited Introduction and Business Overview
10.10.3 Indian Immunologicals Limited Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Indian Immunologicals Limited Veterinary Anthrax Vaccines Products Offered
10.10.5 Indian Immunologicals Limited Recent Development
10.11 Institute for Biological Products
10.11.1 Institute for Biological Products Company Information
10.11.2 Institute for Biological Products Introduction and Business Overview
10.11.3 Institute for Biological Products Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Institute for Biological Products Veterinary Anthrax Vaccines Products Offered
10.11.5 Institute for Biological Products Recent Development
10.12 Intervac (PVT) Ltd
10.12.1 Intervac (PVT) Ltd Company Information
10.12.2 Intervac (PVT) Ltd Introduction and Business Overview
10.12.3 Intervac (PVT) Ltd Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Intervac (PVT) Ltd Veterinary Anthrax Vaccines Products Offered
10.12.5 Intervac (PVT) Ltd Recent Development
10.13 JOVAC
10.13.1 JOVAC Company Information
10.13.2 JOVAC Introduction and Business Overview
10.13.3 JOVAC Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.13.4 JOVAC Veterinary Anthrax Vaccines Products Offered
10.13.5 JOVAC Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Veterinary Anthrax Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Veterinary Anthrax Vaccines Industrial Chain Analysis
11.4 Veterinary Anthrax Vaccines Market Dynamics
11.4.1 Veterinary Anthrax Vaccines Industry Trends
11.4.2 Veterinary Anthrax Vaccines Market Drivers
11.4.3 Veterinary Anthrax Vaccines Market Challenges
11.4.4 Veterinary Anthrax Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Veterinary Anthrax Vaccines Distributors
12.3 Veterinary Anthrax Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
